82,000 Toyota, Lexus Vehicles Recalled for Instrument Panel Issue
Toyota is recalling approximately 82,000 Toyota and Lexus vehicles for an instrument panel issue where certain areas may go blank during startup, preventing important warnings from displaying and increasing crash risk. Affected models include 2024-25 Land Cruiser SUVs, Mirai sedans, and 2024-25 UX and GX SUVs. Dealers will update the combiner meter software for free, and owners will be notified by late July.
ASML vs. KLAC: Which Semiconductor Equipment Stock Is the Better Buy?
This article compares ASML Holding (ASML) and KLA Corporation (KLAC), two key players in the semiconductor equipment market, evaluating their potential for sustainable growth. While ASML dominates in EUV lithography systems crucial for AI chips, KLAC specializes in process control and yield management. Both companies benefit from the booming AI market, strong financials, and commitment to shareholder returns, with ASML ultimately deemed to have an edge due to its valuation and recent price appreciation.
Lockheed Martin Corp stock (US5398301094): defense heavyweight steadies as sector focus turns to long-term demand
Lockheed Martin shares are trading in the mid-$530s on the NYSE, reflecting investor sentiment on sustained defense spending, valuation, and program execution risks. The company continues to position its portfolio across various defense technologies amidst elevated global security spending and modernization programs. The stock's performance is closely watched by investors as a barometer for long-cycle military procurement and is influenced by multi-year contracts and capital returns.
ASML vs. KLAC: Which Semiconductor Equipment Stock Is the Better Buy?
This article compares two semiconductor equipment giants, ASML Holding (ASML) and KLA Corporation (KLAC), to determine which is the better investment. ASML dominates in EUV lithography systems crucial for advanced AI chips, while KLAC specializes in process control and yield management. Both companies are benefiting from the AI boom, but ASML appears to have an edge due to its leadership in EUV technology, strong order backlog, and favorable valuation.
CECO Environmental and Thermon Group Stockholders Approve Strategic Merger: Transaction Details and Closing Timeline
Shareholders of CECO Environmental (Nasdaq: CECO) and Thermon Group Holdings (NYSE: THR) have overwhelmingly approved their strategic merger, with the transaction expected to close around June 1, 2026. Thermon stockholders had options for cash, stock, or mixed consideration, with specific proration details for each. The companies anticipate creating a scaled platform for environmental and thermal solutions, aiming for significant shareholder value despite integration risks.
Bank of America hits key profitability target years ahead of schedule
Bank of America has achieved its 16% return on tangible common equity target years ahead of its original three-to-five-year schedule. CEO Brian Moynihan noted that the bank's momentum is holding after reaching this significant profitability milestone. The accomplishment was highlighted in an article by the Charlotte Business Journal.
Rivian Announces R2 First Delivery, Test-Drive Dates
Rivian is set to begin deliveries of its R2 electric SUV on June 9, starting with the R2 Performance with Launch Package. On the same day, reservation holders will be invited to place orders, and test drives will become available at Rivian Service + Demo Centers. The R2 Premium and Standard trims are expected to follow in late 2026 and 2027, respectively.
AbbVie’s ADC Strategy Notches Another Win With FDA Approval in Ultra-Rare Blood Cancer
AbbVie received FDA approval for Decnupaz, an antibody-drug conjugate (ADC), to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN), an ultra-rare blood cancer. This approval follows the 2023 acquisition of ImmunoGen, which brought Decnupaz into AbbVie's pipeline, and further strengthens the company's oncology strategy focused on ADCs. The drug showed promising remission rates in clinical trials for both treatment-naïve and relapsed/refractory BPDCN patients, despite carrying a black box warning for liver toxicity.
Dollar General Rally Puts Russell 1000 Retail Focus
Discount retail sentiment is experiencing a shift due to evolving earnings expectations, effective store operations, and a recovery in margins, alongside a growing trend of value-focused shopping. Dollar General's shares gained attention as the market anticipates upcoming results and signs of a broader retail recovery. Key factors to watch for the company include sales trends, margin recovery, inventory control, and store execution.
Dominion Energy raised to Buy at Jefferies as cheap way to play NextEra ahead of merger (D:NYSE)
Jefferies has upgraded Dominion Energy (D) shares to Buy from Hold, increasing its price target to $76 from $65. The upgrade is based on the expectation that the NextEra (NEE) takeover will be approved. Dominion Energy's stock was up 1.1% following the upgrade.






